VHL vitasora health limited

phase ii trial of tg4040

  1. 520 Posts.
    Transgene Announces Opening of First Clinical Site for its
    Phase II Trial of TG4040 for the Treatment of Chronic
    Hepatitis C

    http://www.transgene.fr/index.php?option=com_press_release&task=download&id=167&l=en
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.6¢
Change
0.000(0.00%)
Mkt cap ! $44.68M
Open High Low Value Volume
2.6¢ 2.6¢ 2.6¢ $143.8K 5.533M

Buyers (Bids)

No. Vol. Price($)
1 68000 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 220386 3
View Market Depth
Last trade - 14.06pm 13/08/2025 (20 minute delay) ?
VHL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.